Company Filing History:

13 out of 59

Egyt Gyogyszervegyeszeti Gyar

patents

Richter Gedeon Vegyeszeti Gyar Rt

patents

Years Active: 1978-1989

Loading Chart...

17 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 4871846 - Process for the preparation of condensed as-triazine derivatives (1989-10-03),

2. 4753938 - Condensed as-triazine derivatives (1988-06-28),

3. 4727074 - 2-(phenylmethylene)-1-(diaminoalkoxy) cycloalkanes and their (1988-02-23),

4. 4665083 - Iminothiazolidine derivatives (1987-05-12),

5. 4621101 - Pharmaceutical compositions with antianginal activity (1986-11-04),

6. 4419355 - Condensed as-triazine derivatives and method of using the same (1983-12-06),

7. 4395413 - Oxime ethers and pharmaceutical compositions containing the same (1983-07-26),

8. 4342766 - Novel dihydro-as-triazino[5,6-c]quinoline derivatives and a process for (1982-08-03),

9. 4342762 - Basic ethers and pharmaceutical compositions containing the same (1982-08-03),

10. 4324894 - Aminoisoquinoline derivatives (1982-04-13),

11. 4285942 - Cyclododecanone oximes (1981-08-25),

12. 4259257 - 1-Phenyl-2-amino-1,3-propanediol-N-aryloxyalkyl derivatives (1981-03-31),

13. 4229350 - Dibenzo[d,g][1,3,6]dioxazocine derivatives (1980-10-21),

14. 4208410 - Dibenzo[d,g][1,3,6]dioxazocine derivatives (1980-06-17),

15. 4127576 - Nortropine-carbazate derivatives (1978-11-28),

Title: Katalin Grasser: Innovator in Condensed Triazine Derivatives

Introduction

Katalin Grasser is a notable inventor based in Budapest, Hungary, recognized for his significant contributions to the field of chemistry, particularly in the development of condensed triazine derivatives. With a total of 17 patents to his name, Grasser’s work continues to influence both academia and industry.

Latest Patents

Among his latest patents, Grasser has introduced processes for the preparation of condensed as-triazine derivatives. One notable patent details a method for synthesizing compounds characterized by a specific formula, which includes various alkyl groups as substituents. Another patent focuses on new compounds within the general formula I, which consist of alkyl, cycloalkyl, or aryl groups, often substituted with halogen, nitro, and other functional groups. These innovations highlight Grasser's expertise in organic synthesis and compound development.

Career Highlights

Throughout his career, Katalin Grasser has held positions in prominent pharmaceutical companies such as Egyt Gyógyszervegyészeti Gyár and Egis Gyógyszergyár. His work in these organizations has contributed to the advancement of pharmaceutical chemistry and has enabled the production of innovative compounds that cater to various therapeutic needs.

Collaborations

Grasser has collaborated with several noteworthy colleagues throughout his career, including Lujza E. Petocz and Ibolya Kosoczky. These partnerships have fostered a collaborative environment conducive to innovative research and development in the pharmaceutical sector.

Conclusion

Katalin Grasser's contributions to the field of chemistry are invaluable, reflecting his dedication to innovation and research. With numerous patents and collaborations with esteemed professionals, he continues to be a driving force in the development of new chemical entities and processes, enhancing the landscape of pharmaceutical sciences.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com